SynthesisBMC public health2025
Prevalence and risk factors of hepatitis B and C among prison inmates in Nigeria: a systematic review and meta-analysis.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B (HBV) and hepatitis C (HCV) infections are significant global public health challenges. Correctional facilities face amplified and disproportionate risks due to overcrowding, limited healthcare access, and high-risk behaviours. There is a lack of consolidated prevalence and risk factor data on viral hepatitis in Nigerian correctional settings. This study synthesizes evidence on the prevalence of HBV and HCV, risk factors, and regional disparities within Nigerian correctional facilities.
methodsFollowing PRISMA 2020 guidelines, we conducted a systematic review and meta-analysis of 13 cross-sectional studies (2009–2024). Databases (PubMed, Scopus, Web of Science, Dimensions and Google Scholar) were searched. A random-effects model was used to calculate pooled prevalence estimates. Sensitivity and subgroup analyses were performed to explore heterogeneity and regional variations. Studies reporting prevalence data using validated diagnostic methods (rapid tests and/or ELISA) were analysed. We extracted information on study characteristics, geographic regions, inmate demographics, testing modalities, and reported risk factors. Risk factors were evaluated using odds ratios (ORs) and 95% confidence intervals (CIs).
resultsPooled HBV prevalence in Nigerian correctional facilities was 14% (95% CI: 10–19%; n = 2,586) and HCV 10% (95% CI: 4–19%; n = 861). Northern Nigeria reported higher HBV prevalence (19% vs. 6% in the South), while HCV was marginally higher in the South compared to the North (14% vs. 8%). Illicit drug use (HBV: OR = 8.96; HCV: OR = 9.26), blood oath-taking (HBV: OR = 6.57; HCV: OR = 4.57), and marital status (married inmates, OR = 4.37) were significant risk factors. Sharing sharp objects increased HCV risk (OR = 2.14). Other variables, such as blood transfusion, intravenous drug use, condom use, and duration of incarceration, did not show statistically significant associations, likely due to heterogeneity across studies.
conclusionsThis study highlights a high prevalence of HBV and HCV among inmates in Nigerian correctional facilities, primarily influenced by structural and behavioural determinants. These findings point to the urgent need for tailored, comprehensive interventions, such as routine screening, targeted HBV catch-up vaccination, and harm reduction initiatives within the prison system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.